Amjevita

Active Ingredient(s): Adalimumab-atto
FDA Approved: * September 23, 2016
Pharm Company: * AMGEN INC
Category: Immunosuppressive

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Amjevita Overview

Adalimumab, sold under the trade name Humira among others, is a medication used to treat rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, chronic psoriasis, hidradenitis suppurativa, and juvenile idiopathic arthritis. In rheumatoid arthritis, adalimumab has a response rate similar to methotrexate, and in combination, it nearly doubles the response rate of methotrexate alone.[1] Adalimumab is a TNF-inhibiting, anti-inflammatory, biologic m...

Read more Amjevita Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Adalimumab

Recent Amjevita Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Adalimumab-atto
  • Injection: 20mg/0.4ml, 40mg/0.8ml
  • Syringe: 40mg/0.8ml
  • Vial: 40mg/0.8ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Adalimumab-atto or a similar ingredient: (3 results)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. Site content is Copyright © 2005-2017 MedsChat.com and is protected under U.S. and International Copyright laws. All Rights Reserved. This page was last updated on 23 June 2017.

We are committed to your privacy.

Copyright © 2005-2017 All Rights Reserved. MedsChat® and The People's Medicine Community® are registered trademarks of Limelight Innovations L.L.C.